Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Atsuko Ohara"'
Autor:
Yuka Kurokawa, Yusuke Kaida, Takuma Hazama, Yosuke Nakayama, Takaomi Otome, Ryo Shibata, Sakuya Ito, Goh Kodama, Nao Nakamura, Takatoshi Kambe, Tomofumi Moriyama, Akiko Nagata, Aki Minami, Ryotaro Ando, Yoshifumi Wada, Miki Sugiyama, Michiaki Usui, Michio Chiba, Atsuo Moriyama, Atsuko Ohara, Hiroshi Miyazaki, Tatsuyuki Kakuma, Kei Fukami
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-10 (2020)
Abstract Background Etelcalcetide is the first intravenously administered calcimimetic agent used to manage secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. We evaluated the safety and efficacy of replacing cinacalcet with etelcalc
Externí odkaz:
https://doaj.org/article/44fc4637fec249aab21820b2c2f391c2
Autor:
Aki Minami, Takuma Hazama, Tatsuyuki Kakuma, Akiko Nagata, Kei Fukami, Ryo Shibata, Miki Sugiyama, Yoshifumi Wada, Nao Nakamura, Yusuke Kaida, Ryotaro Ando, Michio Chiba, Sakuya Ito, Atsuko Ohara, Atsuo Moriyama, Michiaki Usui, Yosuke Nakayama, Tomofumi Moriyama, Goh Kodama, Takaomi Otome, Yuka Kurokawa, Hiroshi Miyazaki, Takatoshi Kambe
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-10 (2020)
Background Etelcalcetide is the first intravenously administered calcimimetic agent used to manage secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. We evaluated the safety and efficacy of replacing cinacalcet with etelcalcetide in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f0375ca161c9872b89b845383b2e102
https://doaj.org/article/44fc4637fec249aab21820b2c2f391c2
https://doaj.org/article/44fc4637fec249aab21820b2c2f391c2
Autor:
Akiko, Nagata, Atsuko, Ohara, Daisuke, Wakasugi, Chikei, Natori, Sakuya, Ito, Kensei, Taguchi, Kei, Fukami, Seiya, Okuda
Publikováno v:
Nihon Jinzo Gakkai shi. 56(5)
The patient was a 48-year-old man hospitalized for jaundice and anemia after a 6-day history of diarrhea. Examination demonstrated hemolytic anemia, renal dysfunction, and thrombocytopenia. Typical hemolytic uremic syndrome (HUS) was suspected based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e42fb18c81ae45b93335520ed87e243a
https://pubmed.ncbi.nlm.nih.gov/25130033
https://pubmed.ncbi.nlm.nih.gov/25130033
Publikováno v:
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 102(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::59f8386aa0669237d03d201114a5f0ed
https://pubmed.ncbi.nlm.nih.gov/24605574
https://pubmed.ncbi.nlm.nih.gov/24605574
Autor:
Seiji Ueda, Seiya Okuda, Koji Yonemoto, Sho-ichi Yamagishi, Rimi Obata, Kei Fukami, Kaoru Ueda, Ryuji Iwatani, Kiyomi Koike, Maki Toyonaga, Atsuko Ohara, Kazuhito Takeda
Publikováno v:
American journal of nephrology. 35(1)
Background/Aims: Myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-positive microscopic polyangiitis patients with renal involvement have been shown to have a progressive clinical course. In this study, we compared the clinical utility o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fefc9b45955a60cb7c2076d0ce9fed02
https://pubmed.ncbi.nlm.nih.gov/22134171
https://pubmed.ncbi.nlm.nih.gov/22134171